Skip to main content
Market intelligence
NBPSector not reported

NovaBridge Biosciences insider activity

In the last 90 days, 1 corporate insider purchased $577,300 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$577,300
Corporate buyers
1
Latest transaction
Jun 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 18, 2026Phillip Andrew DennisChief Medical OfficerSale8,494$0.66$5,606
Jun 1, 2026Cong Claire XuSVP, Clinical DevelopmentSale3,494$3.94$13,766
May 14, 2026Sean Wuxiong CaoSee RemarksSale21,399$1.99$42,584